Collectively, this suggests that the variations in tumor variant LMP1, specifically the point mutations at positions 212 and 366, alter the cooperativity between signaling pathways, result in the activation of novel signaling pathways, or lose the regulation of another signaling pathway activated by B95.8 LMP1. Here, PDLIM7 is linked to neoplasm.